EUROPEAN ENDOCRINOLOGY VOLUME 13 ISSUE 1 – SPRING 2017
We are pleased to welcome you to the spring edition of European Endocrinology. This edition is expertly introduced by Editorial Board member Ashley Grossman and features timely review articles and topical editorials, written by esteemed experts, succinctly examining a wide range of interesting topics including diabetes, obesity and thyroid cancer. We also include an interesting case series on Takotsubo cardiomyopathy.
We begin with a letter from our new Editor-in-Chief, Abd Tahrani. In this letter Dr Tahrani introduces himself and highlights key updates in the endocrinology field from the last year. We are looking forward to working with him and believe his knowledge and expertise will be of great benefit to this journal.
We hope you find this issue useful and that it provides helpful information and discussions that are relevant to your practice and interests. Please enjoy the expert content and we welcome any feedback you may have.
Foreword – European Endocrinology, 2017;13(1):11
It is vital for all of us involved in endocrinology and diabetes to keep abreast of advances in the various fields which will help those for whom we are responsible, our patients. As an endocrinologist with a particular interest in endocrine oncology, I am aware that attending specialist meetings and workshops is to be at […]
Letter from the Editor-in-Chief
I am delighted to take on the role of Editor-in-Chief for European Endocrinology and would like to take this opportunity to introduce myself. I’m a National Institute for Health Research Clinician Scientist at the University of Birmingham and an Honorary Consultant Physician in Diabetes and Endocrinology and Obesity at Heart of England NHS Foundation Trust. […]
The Cellnovo Insulin Delivery System
Autoimmune destruction of pancreatic beta-cells results in absolute insulin deficiency, type 1 diabetes mellitus (T1DM). Insulin therapy is required for people with T1DM to achieve an optimal glycated haemoglobin (HbA1c or A1c) along with controlled dayto- day blood glucose (BG) levels. While a variety of insulin delivery systems are available, factors such as the complexity […]
Latest Developments and Future Perspectives in the Field Of Obesity
In the last five years, we have witnessed significant progress in the management of obesity and associated metabolic disorders, including type 2 diabetes mellitus (T2DM). The evidence comes from well-controlled randomised controlled trials (RCTs) and has changed the management of these conditions in clinic. What we learned from the Action for Health in Diabetes (Look […]
Progress and Problems in Bone and Mineral Disorders
It is highly appealing to manage osteoporosis and reduce risk of fracture by using drugs that can restore bone microarchitecture and bone strength; such drugs are bone anabolic agents. Teriparatide is the only currently licensed anabolic bone drug and has been used clinically for around 15 years,1 and has an important established, albeit narrow, position […]
Recombinant Human Insulin in Global Diabetes Management – Focus on Clinical Efficacy
The International Diabetes Federation (IDF) estimated that the total number of adults (20–79 years) living with diabetes in 2015 was 415 million and that by 2040, the number is predicted to rise to 642 million (see Figure 1).1 In countries with a low healthcare budget, biosynthetic human insulin is the mainstay of effective therapy, and […]
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine
The incidence of thyroid cancer is increasing at a rate of 7% a year; there were an estimated 62,450 cases diagnosed in the US in 2015 alone. The majority of this rise in incidence is explained by the growing number of incidentally detected well-differentiated, early-stage or ‘low-risk’ papillary thyroid cancers (PTCs).3 There is a growing […]
Takotsubo Cardiomyopathy Associated with Levothyroxine Over-replacement
Takotsubo cardiomyopathy (TC), frequently referred as stress-induced cardiopathy, apical ballooning syndrome or ‘broken heart’ syndrome, is characterised by left ventricular ballooning and transient systolic dysfunction. The Japanese term ‘takotsubo’ means a trap to catch an octopus, and its shape resembles this condition’s left ventricular systolic appearance.1 Clinically, TC can mimic an acute coronary syndrome (precordial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!